Literature DB >> 19421051

Evaluation of patients with dry eye for presence of underlying Sjögren syndrome.

Esen Karamursel Akpek1, Alena Klimava, Jennifer E Thorne, Don Martin, Kaevalin Lekhanont, Ann Ostrovsky.   

Abstract

PURPOSE: To evaluate the rate of Sjögren syndrome (SS) in a cohort of patients with dry eye syndrome.
METHODS: Medical records of patients with a primary diagnosis of dry eye syndrome (International Classification of Diseases [ICD] code 375.15 or 370.33) were reviewed retrospectively. Patients who had 2 or more visits to a single dry eye center during a 2-year period (January 2004 to January 2006) were considered.
RESULTS: Two hundred twenty patients with dry eye syndrome were identified. A total of 57 patients (25.9%) had an underlying rheumatic condition: 25 patients (11.4%) had rheumatoid arthritis and 24 (10.9%) had primary Sjögren syndrome (PSS). Majority of the patients with rheumatoid arthritis (96%) carried the diagnosis at the time of presentation. Of all patients with PSS, only 33.3% (8/24) carried the diagnosis at the time of presentation. Fifty percent (12/24) were diagnosed as a result of the initial evaluation. Among those, only 66.6% (8/12) tested SSA (anti-Ro antibodies) or SSB (anti-La antibodies) positive. One third of patients (4/12) tested only antinuclear antibody positive at a titer of <1/320 and required minor salivary gland biopsy for definitive diagnosis. Additional 16.7% (4/24), who were initially serologically negative, eventually underwent minor salivary gland biopsy and became diagnosed with SS.
CONCLUSIONS: PSS seems to be underdiagnosed in patients with dry eye syndrome and should be the focus of diagnostic evaluations. A minor salivary gland biopsy might be required for a definitive diagnosis in a significant proportion of the patients with SS.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19421051      PMCID: PMC2693267          DOI: 10.1097/ICO.0b013e31818d3846

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  20 in total

Review 1.  Current concepts on diagnosis, autoantibodies and therapy in Sjögren's syndrome.

Authors:  R Jonsson; H J Haga; T P Gordon
Journal:  Scand J Rheumatol       Date:  2000       Impact factor: 3.641

Review 2.  Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group.

Authors:  C Vitali; S Bombardieri; R Jonsson; H M Moutsopoulos; E L Alexander; S E Carsons; T E Daniels; P C Fox; R I Fox; S S Kassan; S R Pillemer; N Talal; M H Weisman
Journal:  Ann Rheum Dis       Date:  2002-06       Impact factor: 19.103

3.  Incidence of dry eye in an older population.

Authors:  Scot E Moss; Ronald Klein; Barbara E K Klein
Journal:  Arch Ophthalmol       Date:  2004-03

4.  Sjögren's syndrome: association of anti-Ro(SS-A) antibodies with vasculitis, hematologic abnormalities, and serologic hyperreactivity.

Authors:  E L Alexander; F C Arnett; T T Provost; M B Stevens
Journal:  Ann Intern Med       Date:  1983-02       Impact factor: 25.391

5.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.

Authors:  F C Arnett; S M Edworthy; D A Bloch; D J McShane; J F Fries; N S Cooper; L A Healey; S R Kaplan; M H Liang; H S Luthra
Journal:  Arthritis Rheum       Date:  1988-03

6.  Prevalence of and risk factors for dry eye syndrome.

Authors:  S E Moss; R Klein; B E Klein
Journal:  Arch Ophthalmol       Date:  2000-09

7.  Keratoconjunctivitis sicca in rheumatoid arthritis.

Authors:  G M Mody; J C Hill; O L Meyers
Journal:  Clin Rheumatol       Date:  1988-06       Impact factor: 2.980

8.  Conjunctival T-cell subpopulations in Sjögren's and non-Sjögren's patients with dry eye.

Authors:  Michael E Stern; Jianping Gao; Tammy A Schwalb; Mylinh Ngo; David D Tieu; Chi-Chao Chan; Brenda L Reis; Scott M Whitcup; Darby Thompson; Janine A Smith
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-08       Impact factor: 4.799

9.  Systemic lupus erythematosus: a review of clinico-laboratory features and immunogenetic markers in 150 patients with emphasis on demographic subsets.

Authors:  M C Hochberg; R E Boyd; J M Ahearn; F C Arnett; W B Bias; T T Provost; M B Stevens
Journal:  Medicine (Baltimore)       Date:  1985-09       Impact factor: 1.889

10.  Ocular involvement in scleroderma.

Authors:  R H West; A J Barnett
Journal:  Br J Ophthalmol       Date:  1979-12       Impact factor: 4.638

View more
  35 in total

1.  The efficacy of topical 0.05 % cyclosporine A in patients with dry eye disease associated with Sjögren's syndrome.

Authors:  Hülya Devecı; Senol Kobak
Journal:  Int Ophthalmol       Date:  2014-01-19       Impact factor: 2.031

2.  Comparison of corneal biomechanics in Sjögren's syndrome and non-Sjögren's syndrome dry eyes by Scheimpflug based device.

Authors:  Qin Long; Jing-Yi Wang; Dong Xu; Ying Li
Journal:  Int J Ophthalmol       Date:  2017-05-18       Impact factor: 1.779

3.  Supra-lacrimal protein-based carriers for cyclosporine A reduce Th17-mediated autoimmunity in murine model of Sjögren's syndrome.

Authors:  Hao Guo; Yaping Ju; Minchang Choi; Maria C Edman; Stan G Louie; Sarah F Hamm-Alvarez; J Andrew MacKay
Journal:  Biomaterials       Date:  2022-02-26       Impact factor: 12.479

4.  Meibomian gland atrophy with duration of Sjogren's syndrome in adult females.

Authors:  Sung Rae Noh; Jae Lim Chung; Jeong Min Lee; Kyoung Yul Seo; Kyungmin Koh
Journal:  Int Ophthalmol       Date:  2021-08-19       Impact factor: 2.031

5.  Clusterin from human clinical tear samples: Positive correlation between tear concentration and Schirmer strip test results.

Authors:  Valerie Yu; Dhruva Bhattacharya; Andrew Webster; Aditi Bauskar; Charles Flowers; Martin Heur; Shravan K Chintala; Tatsuo Itakura; Mark R Wilson; Joseph T Barr; Shinwu Jeong; Mingwu Wang; M Elizabeth Fini
Journal:  Ocul Surf       Date:  2018-08-02       Impact factor: 5.033

Review 6.  Sjögren's Syndrome: More Than Just Dry Eye.

Authors:  Esen K Akpek; Vatinee Y Bunya; Ian J Saldanha
Journal:  Cornea       Date:  2019-05       Impact factor: 2.651

7.  Prevalence of Novel Candidate Sjogren Syndrome Autoantibodies in the Dry Eye Assessment and Management (DREAM) Study.

Authors:  Vatinee Y Bunya; Gui-Shuang Ying; Maureen G Maguire; Eric Kuklinski; Meng C Lin; Ellen Peskin; Penny A Asbell
Journal:  Cornea       Date:  2018-11       Impact factor: 2.651

8.  Relationships between activated dendritic cells and dry eye symptoms and signs.

Authors:  Harry Levine; Jodi Hwang; Harrison Dermer; Divy Mehra; William Feuer; Anat Galor
Journal:  Ocul Surf       Date:  2021-06-06       Impact factor: 6.268

Review 9.  Beyond dry eye: how co-morbidities influence disease phenotype in dry eye disease.

Authors:  Yonghoon Lee; Minji Kim; Anat Galor
Journal:  Clin Exp Optom       Date:  2021-08-08       Impact factor: 2.742

10.  Preliminary Screening Questionnaire for Sjögren's Syndrome in the Rheumatology Setting.

Authors:  Kimberley Yu; Gui-Shuang Ying; Frederick B Vivino; John A Gonzales; Mina Massaro-Giordano; Vatinee Y Bunya
Journal:  J Clin Rheumatol       Date:  2022-03-01       Impact factor: 3.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.